ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Hannah Linden, MD, Highlights AMEERA-1 for ER+/HER2- mBC"
Episode Synopsis
Dr Linden shares encouraging results from the AMEERA-1 trial on SAR439859, an oral estrogen receptor degrader, for ER+/HER2- metastatic breast cancer, presented at the virtual 2020 SABCS Annual Meeting.
In God we trust